Genenta Science SpA (GNTA) is a forward-thinking clinical-stage biotechnology firm based in Milan, Italy, focused on pioneering hematopoietic stem cell gene therapies for the treatment of solid tumors. Utilizing advanced genetic engineering technologies, Genenta aims to revolutionize cancer care through its innovative, transformative therapies. The company's promising pipeline, coupled with strategic collaborations, positions it as a significant player in the oncology field, offering institutional investors a unique opportunity to engage with breakthrough advancements in biotechnology. Show more
Location: VIA OLGETTINA NO. 58, MILAN, MI, ITALY, 20132, Milan, MI, 20132, USA | Website: https://www.genenta.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
23.11M
52 Wk Range
$0.98 - $6.20
Previous Close
$1.17
Open
$1.12
Volume
328,692
Day Range
$0.98 - $1.15
Enterprise Value
15.3M
Cash
5.177M
Avg Qtr Burn
-5.515K
Insider Ownership
37.43%
Institutional Own.
10.06%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Temferon Details Glioblastoma | Phase 1/2 Update |
